Symptoms of Long-COVID Can Last Up to Two Years After Infection, Say END-VOC Researchers
Almost one in four people infected with SARS-CoV-2 suffered from [...]
T Cells Hold the Line Against New COVID-19 Variants
This study underscores the key role of T cells in [...]
Mpox Outbreak in Africa Can Still be Controlled and Eliminated, Says END-VOC Leader
In a recent comment published in The Lancet, Ibrahim Abubakar [...]
END-VOC Welcomes a New Partner to the Project
This summer, the Instituto de Medicina Molecular (IMM) Joao Lobo [...]
ENDVOC’s Fourth General Assembly in London Shows Great Progress
The ENDVOC consortium is now in a position to step [...]
ENDVOC Researchers Recommend Strenghtening Immunity against COVID-19 in People with Cancer
This is the most exhaustive research carried out so far [...]
ENDVOC Researchers Reveal the Challenges of Measuring COVID-19 Antibodies in Africa
Antibodies to malaria and other pathogens can cause false seropositive [...]
Humans Transmit More Viruses to Animals Than Thought
END-VOC researchers analysed nearly 60,000 viral genomes and found that [...]
A Cohort of HealthCare Workers Helps Predict Protection against Omicron Infections
New results from a cohort of Catalan healthcare workers support [...]
Our partners in Brazil: a cohort of patients with comorbidities
In this interview, Fernando Val and his colleagues in Manaus, [...]
